Search results
Die Hikma Pharma GmbH vertreibt ein hochwertiges Produktportfolio vor allem im Bereich Antibiotika/Antiinfektiva und onkologischer Indikationen.
Hikma launches Midazolam Injection, USP, in a prefilled syringe in the US Press Release, Corporate 08 May 2024 Hikma launches Midazolam Injection, USP, in a prefilled syringe in the US Hikma has strong start to 2024, with continued momentum across all businesses.
Insight, Corporate 29 April 2024. Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated. Press Release, Financial Results 25 April 2024.
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was ...
Mar 3, 2024 · Hikma Pharmaceuticals PLC is a pharmaceutical company. The principal activities of the Company are the development, manufacture and marketing of a range of generic, branded and in-licensed ...
Core to Hikma’s strategy is having a strong local presence in our markets. We have an extensive network of manufacturing facilities across the US, MENA and Europe and are continually expanding this presence by building new sites and expanding existing ones. Through our local sites, we are uniquely positioned to respond quickly to evolving ...
At Hikma, being a responsible business sits at the very heart of what we do. Learn more about how we put better health within reach, every day and make a difference to people’s lives. Explore responsibility. Careers.
